M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

NCT03840915 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Nab-paclitaxel
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: M7824
DRUG: Carboplatin
DRUG: Carboplatin
DRUG: Bintrafusp alfa
DRUG: Paclitaxel

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]